The 25th Innovation Seminar for Future Drug Discovery and Medical Care
Date：9 July （Wed.） 17:30～19:00
Venue：Conference Room(5F), Creative Research Institution, HU
Novel fusion between Future Drug Discovery and Medical Care
Chair：Kota Kodama, Ph.D., Coordinating Office
||Nano-structural design of RNA for biomedical purpose|
Hiroshi Abe, Ph.D.
Associate Professor, Laboratory of Organic Chemistry for Drug Development, Faculty of Pharmaceutical Sciences, Hokkaido University
Nano-structural design of RNA offers various functions for biomedical purpose. For example, we showed nano-circular RNA provided endless protein translation. The lecture presents several our examples.
||Signaling pathways involved in influenza virus entry into host cells|
Yusuke Ohba, M.D., Ph.D.
Professor, Department of Cell Physiology, Hokkaido University Graduate School of Medicine
Influenza A viruses are internalized into host cells via endocytosis. We recently identified the signaling network that regulates endocytosis and influenza virus entry, in which intracellular Ca2+ plays a central role.
||The development of therapeutic drugs for emerging infectious diseases from the research and development experience of the anti-viral drugs|
Akihiko Sato, D.V.D., Ph.D.
Team Leader, Emerging Infectious Diseases, Shionogi & Co. Ltd., Discovery Research Laboratory for Core Therapeutic Areas
We succeeded in research and development of anti-HIV drug Dolutegravir in Shionogi. We make use of this experience and want to challenge the research of emerging infectious disease virus therapeutic drugs.
Contact to：Ms. Wada, Coordinating Office Medical Branch （Direct：7798）